RedHill Biopharma Announces Positive Final Results with Primary and Secondary Endpoints Met in Phase 1 Study with YELIVA™ in Advanced Solid Tumors Biotech Investing
Helius Medical Announces Results from a Case Series of Subjects with Advanced MS Medical Device Investing
Home Health Monitoring Devices Evolving to Deliver More Than Just Emergency Responses Medical Device Investing
Seven Bridges Is Named to MIT Technology Review’s Annual 50 Smartest Companies List Biotech Investing
Agriculture Environmental Stewardship Act of 2016 Introduced in U.S. House to Create Tax Incentive for Investments in Biogas and Nutrient Recovery Agriculture Investing
Catalyst Biosciences Receives Patents Covering its Hemostasis and Anti-Complement Programs Biotech Investing
Adaptimmune Receives Positive Opinion for Orphan Drug Designation in the European Union for SPEAR™ T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma Biotech Investing
McKesson Specialty Health Launches Optimization Toolkit for Oncology In-Office Dispensing Program Medical Device Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
